ethacrynic acid has been researched along with cromolyn sodium in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Finet, M; Hanf, R; Latournerie, V; Le Filliatre, G; Renaud, JF; Sayah, S | 1 |
2 other study(ies) available for ethacrynic acid and cromolyn sodium
Article | Year |
---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Cyclo-oxygenase and lipoxygenase pathways in mast cell dependent-neurogenic inflammation induced by electrical stimulation of the rat saphenous nerve.
Topics: Animals; Benzoquinones; Cromolyn Sodium; Cyclooxygenase Inhibitors; Electric Stimulation; Enzyme Inhibitors; Ethacrynic Acid; Gene Expression Regulation, Enzymologic; Indoles; Lipoxygenase; Lipoxygenase Inhibitors; Male; Mast Cells; Neurogenic Inflammation; Peripheral Nerves; Polysaccharides; Prostaglandin-Endoperoxide Synthases; Pyrilamine; Quinolines; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction; Sulfonamides; Thiophenes; Vasodilation | 2001 |